ROCÍO
GARCÍA CARBONERO
Profesora asociada de Ciencias de la Salud
Instituto de Biomedicina de Sevilla
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Biomedicina de Sevilla (8)
2021
-
Sunitinib and Evofosfamide (TH-302) in Systemic Treatment-Naïve Patients with Grade 1/2 Metastatic Pancreatic Neuroendocrine Tumors: The GETNE-1408 Trial
Oncologist, Vol. 26, Núm. 11, pp. 941-949
2018
-
Telotristat ethyl in carcinoid syndrome: Safety and efficacy in the TELECAST phase 3 trial
Endocrine-Related Cancer, Vol. 25, Núm. 3, pp. 309-322
2017
-
Prognostic relevance of Src activation in stage II-III colon cancer
Human Pathology, Vol. 67, pp. 119-125
2014
-
GATA4 loss in the septum transversum mesenchyme promotes liver fibrosis in mice
Hepatology, Vol. 59, Núm. 6, pp. 2358-2370
2013
-
Epithelial-mesenchymal transition markers in the differential diagnosis of gastroenteropancreatic neuroendocrine tumors
American Journal of Clinical Pathology, Vol. 140, Núm. 1, pp. 61-72
-
Identification of oxidative stress related proteins as biomarkers for lung cancer and chronic obstructive pulmonary disease in bronchoalveolar lavage
International Journal of Molecular Sciences, Vol. 14, Núm. 2, pp. 3440-3455
-
Inhibition of HSP90 molecular chaperones: Moving into the clinic
The Lancet Oncology, Vol. 14, Núm. 9
-
Sorafenib in combination with oxaliplatin, leucovorin, and fluorouracil (modified FOLFOX6) as first-line treatment of metastatic colorectal cancer: The RESPECT trial
Clinical Cancer Research, Vol. 19, Núm. 9, pp. 2541-2550